English
Bulgarian
Chinese (Simplified)
Croatian
Czech
Danish
Dutch
Finnish
French
German
Greek
Hebrew
Hindi
Indonesian
Italian
Japanese
Korean
Macedonian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swedish
Thai
Turkish
Vietnamese
News
Getting ready for EHA 2025 – Your CML meeting schedule
May 2025 - The countdown to the European Hematology Association (EHA) 2025 Congress has begun! From June 12-15 in Milan, the international CML community will come together to explore groundbreaking developments in CML biology, therapy, and patient care.
To make sure you don’t miss any important sessions and discussions, we have compiled an overview of CML related sessions at EHA2025 Congress for you.
Read on for more information...
Isabella’s still going strong - Another amazing fundraising day from our youngest supporter
Since 2020, Isabella has been raising money for the iCMLf in honor of her mum, who was diagnosed with CML that year. Over the years, she’s run fun runs, rallied her school community, and inspired people around the world with her determination and heart.
And she’s not done yet.
A Turning Point in Cancer: Dr. Brian Druker Reflects on 25 Years of TKIs
As part of the iCMLf’s 25 Years of TKIs campaign, we spoke to Dr. Brian Druker - whose work helped transform CML from a fatal disease to a manageable condition. He shared the moments that shaped this journey, the challenges along the way, and the hope that still drives him today.
Explore the new CML Clinical Trials Resource on the iCMLf website
April 2025 - We’re excited to introduce a new resource from the iCMLf created to support the global CML community:
The iCMLf CML Clinical Trials Overview is now live!
Finding reliable, up-to-date information on clinical trials can be time-consuming and overwhelming. That’s why we’ve developed a dedicated webpage to simplify your search for trials investigating new compounds to treat CML.
We've compiled CML-specific listings from clinicaltrials.gov into a single, easy-to-navigate page - with a downloadable searchable spreadsheet to help tailor your search.
🔍 What you’ll find:
- Two categorised lists of CML trials:
• Recruiting now – Trials currently enrolling patients (and potentially sites)
• Not yet recruiting – Studies in preparation stages
Hepatitis B and CML survey extended for one more week! – Deadline April 24th
April 2024 - Thank you to everyone who shared their experiences in the iCMLf Hepatitis B Virus (HBV) and CML Screening and Management Survey.
Your contributions are essential to improving the understanding and management of Hepatitis B for people living with CML. This global collaboration - and the insights gained from your clinical practice - bring us one step closer to informing future recommendations and enhancing patient care.
Submissions are now open until April 24th to help close regional data gaps.
Second pediatric CML case review: TFR after 9 years on imatinib without prior DMR
April 2025 - We are pleased to share the second publication in our ongoing series of pediatric CML (pCML) case reviews from low and middle-income countries (LMICs). These cases reflect the complexities inherent in managing pCML in resource-limited settings and aim to provide a comprehensive discussion from various perspectives to enhance knowledge and improve patient outcomes.
The latest case, published in the March edition of Case Reports in Oncology Medicine, highlights a challenging case from Brazil. Experts discuss treatment discontinuation in a child with CML who has not achieved a sustained deep molecular response.
